To study an involvement of glomerular endothelial cells in the development of anti-Thy-1 nephritis, we examined the expression of endothelial cell adhesion molecules during the course of this model. Ribonuclease protection assay elucidated that expression of mRNA for intercellular adhesion molecule-1 (ICAM-1) was markedly enhanced in the glomeruli with a peak at 2 h (6.5-fold, p < 0.05) after the anti-Thy-1 antibody injection when mesangial cell lysis was recognized and IL-1β mRNA expression was induced in the glomeruli. The glomerular ICAM-1 was predominantly localized in the endothelial cells and was intensely immunostained at day 1 in the glomerular endothelial cells. In contrast, platelet endothelial cell adhesion molecule-1 (PECAM-1) and vascular endothelial-cadherin mRNA expression increased gradually with a peak at day 6 (2.6-fold (p < 0.05) and 4.2-fold (p < 0.05), respectively) in the glomeruli with mesangial proliferative lesion. PECAM-1 was also immunolocalized in the glomerular endothelial cells and the immunoreactivity was greatly enhanced at day 6. Glomerular expression of vascular cell adhesion molecule-1 and endothelial leukocyte adhesion molecule-1 (E-selectin) was unchanged at a low level during the course of anti-Thy-1 nephritis. Blocking of ICAM-1 by administration of anti-ICAM-1 antibody showed significant decrease in the number of polymorphonuclear leukocytes accumulating in the glomeruli by 45.7% (9.4 ± 0.2 vs. 5.1 ± 0.1 per glomerular cross section, p < 0.01) at 2 h. These results suggest a significant involvement of glomerular endothelial cells in the development and repair of anti-Thy-1 nephritis via direct or indirect intercellular interactions between mesangial cells and glomerular endothelial cells.

Keywords:
ICAM-1, Anti-Thy-1 nephritis, Glomerular endothelial cell
1.
Stewart RJ, Marsden PA: Vascular endothelial cell activation in models of vascular and glomerular injury. Kidney Int 1994;45:S37–S44.
2.
Fujinaka H, Yamamoto T, Feng L, Kawasaki K, Yaoita E, Hirose S, Goto S, Wilson CB, Uchiyama M, Kihara I: Crucial role of CD-8 positive lymphocytes in glomerular expression of ICAM-1 and cytokines in crescentic glomerulonephritis of WKY rats. J Immunol 1997;158:4978–4983.
3.
Kawasaki K, Yaoita E, Yamamoto T, Tamatani T, Miyasaka M, Kihara I: Antibodies against intercellular adhesion molecule-1 and lymphocyte function-associated antigen-1 prevent glomerular injury in rat experimental crescentic glomerulonephritis. J Immunol 1993;150:1074–1083.
4.
Mulligan MS, Johnson KJ, Todd RF III, Issekutz TB, Miyasaka M, Tamatani T, Smith CW, Anderson DC, Ward PA: Requirements for leukocyte adhesion molecules in nephrotoxic nephritis. J Clin Invest 1993;91:577–587.
5.
Bishop GA, Hall BM: Expression of leukocyte and lymphocyte adhesion molecule in the human kidney. Kidney Int 1989;36:1078–1085.
6.
Brady HR: Leukocyte adhesion molecules and kidney diseases. Kidney Int 1994;45:1285–1300.
7.
Yamamoto T, Wilson CB: Quantitative and qualitative studies of antibody-induced mesangial cell damage in the rat. Kidney Int 1987;32:514–525.
8.
Yamamoto T, Wilson CB: Complement dependence of antibody-induced mesangial cell injury in the rat. J Immunol 1987;138:3758–3765.
9.
Johnson RJ: What mediates progressive glomerulosclerosis? The glomerular endothelium comes of age. Am J Pathol 1997;151:1179–1181.
10.
Iruela-Aripse L, Gordon K, Hugo C, Duijvestijn AM, Claffey KP, Reilly M, Couser WG, Alpers CE, Johnson RJ: Participation of glomerular endothelial cells in the capillary repair of glomerulonephritis. Am J Pathol 1995;147:1715–1727.
11.
Shimizu A, Kitamura H, Masuda Y, Ishizaki M, Sugisaki Y, Yamanaka N: Glomerular capillary regeneration and endothelial cell apoptosis in both reversible and progressive models of glomerulonephritis. Contrib Nephrol. Basel, Karger, 1996, vol 118, pp 29–40.
12.
Hirose S, Yamamoto T, Feng L, Yaoita E, Kawasaki K, Goto S, Fujinaka H, Wilson CB, Arakawa M, Kihara I: Expression and localization of cyclooxygenase isoforms and cytosolic phospholipase A2 in anti-Thy-1 glomerulonephritis. J Am Soc Nephrol 1998;9:408–416.
13.
Pober JS, Gimbrone MA, Lapierre LA, Mendrick DL, Fiers W, Rothlein R, Springer TA: Overlapping patterns of activation of human endothelial cells by interleukin-1, tumor necrosis factor and immune interferon. J Immunol 1986;137:1893–1896.
14.
Rothlein R, Czajkowski M, O’Neill MM, Marlin SD, Mainolfi E, Merluzzi VJ: Induction of intercellular adhesion molecule-1 on primary and continuous cell lines by pro-inflammatory cytokines. Regulation by pharmacologic agents and neutralizing antibodies. J Immunol 1988;141:1665–1669.
15.
Bevilacqua MP, Pober JS, Mendrick DL, Contran RS, Gimbrone MA Jr: Identification of an inducible endothelial-leukocyte adhesion molecule. Proc Natl Acad Sci USA 1987;84:9238–9242.
16.
Luscinskas FW, Brock AF, Arnaout MA, Gimbrone MA Jr: Endothelial-leukocyte adhesion molecule-1 dependent and leukocyte (CD11/CD18)-dependent mechanisms contribute to polymorphonuclear leukocyte adhesion to cytokine-activated human vascular endothelium. J Immunol 1989;141:2257–2263.
17.
Osborn L, Hession C, Tizard R, Vassallo C, Luhowskyj S, Chi-Rosso G, Lobb R: Direct expression cloning of vascular cell adhesion molecule-1 (VCAM-1), a cytokine-induced endothelial protein that binds to lymphocyte. Cell 1989;59:1203–1211.
18.
Honkanen E, von Willebrand E, Teppo AM, Tornroth T, Riska CG: Adhesion molecules and urinary tumor necrosis factor-α in idiopathic membranous glomerulonephritis. Kidney Int 1998;53:909–917.
19.
Albelda SM, Muller WA, Buck CA, Newman PJ: Molecular and cellular properties of PECAM-1 (endoCAM/CD31): A novel vascular cell-cell adhesion molecule. J Cell Biol 1991;114:1059–1068.
20.
Suzuki S, Sano K, Tanihara H: Diversity of the cadherin family: Evidence for eight new cadherins in nervous tissue. Cell Regul 1991;2:261–270.
21.
Lampugnani MG, Corada M, Caveda L, Breviario F, Dejana E: The molecular organization of endothelial cell to cell junctions: Differential association of plakoglobin and α-catenin in vascular endothelial cadherin. J Cell Biol 1995;129:203–217.
22.
Romer LH, McLean NV, Yan HC, Daise M, Sun J, DeLisser HM: IFN-γ and TNF-α induce redistribution of PECAM-1 (CD31) on human endothelial cells. J Immunol 1995;154:6582–6592.
23.
Stewart RJ, Kashour TS, Marsden PA: Vascular endothelial platelet endothelial cell adhesion molecule-1 expression is decreased by TNF-α and IFN-γ. Evidence for cytokine-induced destabilization of messenger ribonucleic acid transcripts in bovine endothelial cells. J Immunol 1996;156:1221–1228.
24.
Del Maschio A, Zanetti A, Corada M, Rival Y, Ruco L, Lampugnani MG, Dejana E: Polymorphonuclear leukocyte adhesion triggers the disorganization of endothelial cell-to-cell adherens junctions. J Cell Biol 1996;135:497–510.
25.
Albelda SM, Oliver PD, Romer LH, Buck CA: EndoCAM: A novel endothelial cell-cell adhesion molecule. J Cell Biol 1990;110:1227–1237.
26.
Baldwin HS, Shen HM, Yan H, DeLisser HM, Chung A, Mikanin C, Trask T, Kirschbaum NE, Newman PJ, Albelda SM, Buck CA: Platelet endothelial adhesion molecule-1 (PECAM-1/CD31): An alternatively spliced, functionally distinct isoform expressed during mammalian cardiovascular development. Development 1994;120:2539–2553.
27.
Breier G, Breviario F, Caveda L, Berthier R, Schnürch H, Gotsch U, Vestweber D, Risau W, Dejana E: Molecular cloning and expression of murine VE-cadherin in early developing cardiovascular system. Blood 1996;87:630–641.
28.
Goto S, Yamamoto T, Feng L, Yaoita E, Hirose H, Fujinaka H, Kawasaki K, Hattori R, Yui Y, Wilsom CB, Arakawa M, Kihara I: Expression and localization of inducible nitric oxide synthase in anti-Thy-1 glomerulonephritis. Am J Pathol 1995;147:1133–1141.
29.
Xia Y, Feng L, Yoshimura T, Wilson CB: LPS-induced MCP-1, IL-1β and TNF-α mRNA expression in isolated erythrocyte-perfused rat kidney. Am J Physiol 1993;264:F774–F780.
30.
Feng L, Tang WW, Loskutoff DJ, Wilson CB: Dysfunction of glomerular fibrinolysis in experimental antiglomerular basement membrane antibody glomerulonephritis. J Am Soc Nephrol 1993;3:1753–1764.
31.
Kita Y, Takahashi T, Iigo Y, Tamatani T, Miyasaka M, Horiuchi T: Sequence and expression of rat ICAM-1. Biochim Biophys Acta 1992;1131:108–110.
32.
Ballermann BJ: Regulation of bovine glomerular endothelial cell growth in vitro. Am J Physiol 1989;256:C182–C189.
33.
Saeki T, Morioka T, Arakawa M, Shimizu F, Oite T: Modulation of mesangial cell proliferation by endothelial cells in co-culture. Am J Pathol 1991;139:949–957.
34.
Marks RM, Todd RF III, Ward PA: Rapid induction of neutrophil-endothelial adhesion by endothelial complement fixation. Nature 1989;339:314–317.
35.
Foreman KE, Vaporciyan AA, Bonish BK, Jones ML, Johnson KJ, Glovsky MM, Eddy SM, Ward PA: C5a-induced expression of P-selectin in endothelial cells. J Clin Invest 1994;94:1147–1155.
36.
Elices MJ, Osborn L, Takada Y, Crouse C, Luhowski S, Hemler ME, Lobb R: VCAM-1 on activated endothelium interacts with the leukocyte integrin VLA-4 at a site distinct from the VLA-4/fibronectin binding site. Cell 1990;60:577–584.
37.
Muller WA, Weigl SA, Deng X, Phillips DM: PECAM-1 is required for transendothelial migration of leukocytes. J Exp Med 1993;178:449–460.
38.
Vaporciyan AA, DeLisser HM, Yan H, Mendiguren II, Thom SR, Jones ML, Ward PA, Albelda SM: Involvement of platelet endothelial cell adhesion molecule-1 in neutrophil recruitment in vivo. Science 1993;262:1580–1582.
39.
Liao F, Huynh HK, Eiroa A, Greene T, Polizzi E, Muller WA: Migration of monocytes across endothelium and passage through extracellular matrix involve separate molecular domains of PECAM-1. J Exp Med 1995;182:1337–1343.
© 2002 S. Karger AG, Basel
2002
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.